{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T18:52:16Z","timestamp":1691520736685},"reference-count":33,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Background\u2003Antiphospholipid antibodies (APAs) are found quite frequently in patients with non-Hodgkin\u2019s lymphoma (NHL). However, the clinical significance of these antibodies is largely unknown. This study aims to delineate the clinical and prognostic role of APAs in NHL patients.<\/jats:p><jats:p>\n          Patients and Methods\u2003 Consecutive patients of NHL were screened for lupus anticoagulant (LA), IgG\/IgM anticardiolipin antibody, and IgG\/IgM anti-\u03b22-glycoprotein I at the time of diagnosis. Baseline investigations, staging, and treatment were done as per institutional protocol. Patients were followed up until the last known outpatient visit or death. All were screened at each visit for any thromboembolic event. The association of APA status with baseline NHL characteristics and treatment response was evaluated by univariate analysis. Kaplan\u2013Meier survival analysis was used to compare the final outcome in patients with or without APAs. Patients who were initially APA positive were retested for the corresponding antibody at the end of chemotherapy.<\/jats:p><jats:p>\n          Results\u2003Twenty-four out of 105 patients (22.8%) were APA positive at diagnosis. The presence of APA was not significantly associated with NHL stage, histology, International Prognostic Index score, activated partial thromboplastin time, or treatment response. The median duration of follow-up was 15 months. Only four patients developed venous thrombosis; none was APA positive. There was no statistically significant difference in overall survival between the two groups (p\u2009=\u20090.471). Patients, who were APA positive initially, tested negative at the end of treatment, irrespective of treatment response.<\/jats:p><jats:p>\n          Conclusion\u2003APAs are encountered more frequently in NHL patients than in the general population. However, APAs do not correlate with disease severity, thrombosis risk, treatment outcome, or overall survival.<\/jats:p>","DOI":"10.1055\/a-1223-3367","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T23:04:58Z","timestamp":1600211098000},"page":"662-670","source":"Crossref","is-referenced-by-count":2,"title":["Antiphospholipid Antibodies Are Not Associated with Clinical Parameters or Prognostic Outcomes in Patients with Non-Hodgkin's Lymphoma"],"prefix":"10.1055","volume":"40","author":[{"given":"Rimesh","family":"Pal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Varma","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Ahluwalia","sequence":"additional","affiliation":[{"name":"Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Prakash","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,9,15]]},"reference":[{"issue":"12","key":"ref1","first-page":"2833","article-title":"Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review","volume":"27","author":"I N Bruce","year":"2000","journal-title":"J Rheumatol"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"S Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bjc.1995.353","article-title":"Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy","volume":"72","author":"E Zuckerman","year":"1995","journal-title":"Br J Cancer"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1600-0609.1995.tb00214.x","article-title":"Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance","volume":"54","author":"H Ottinger","year":"1995","journal-title":"Eur J Haematol"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1055\/s-0038-1649628","article-title":"Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma","volume":"70","author":"R Stasi","year":"1993","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/10428190009054888","article-title":"The significance of autoantibodies in non-Hodgkin's lymphoma","volume":"40","author":"A Timura\u011fao\u011flu","year":"2000","journal-title":"Leuk Lymphoma"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1600-0609.2005.00620.x","article-title":"Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma","volume":"76","author":"O Bairey","year":"2006","journal-title":"Eur J Haematol"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"M M Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"14","key":"ref9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"key":"ref10","first-page":"1920","volume-title":"Paraneoplastic syndromes","author":"J D Minna","year":"1989"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/1097-0142(19930215)71:4<1384::AID-CNCR2820710433>3.0.CO;2-S","article-title":"Thromboembolism in cancer. Changing trends","volume":"71","author":"J E Naschitz","year":"1993","journal-title":"Cancer"},{"issue":"05","key":"ref12","first-page":"245","article-title":"Tumor interaction with vascular endothelium","volume":"17","author":"H Al-Mondhiry","year":"1987","journal-title":"Haemostasis"},{"issue":"04","key":"ref13","first-page":"482","article-title":"Primary antiphospholipid syndrome","volume":"16","author":"D Alarc\u00f3n-Segovia","year":"1989","journal-title":"J Rheumatol"},{"issue":"18","key":"ref14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJM198605013141817","article-title":"Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant","volume":"314","author":"R Cariou","year":"1986","journal-title":"N Engl J Med"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.autrev.2009.04.001","article-title":"Antiphospholipid antibodies and malignancies","volume":"9","author":"A Tincani","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.semarthrit.2005.07.003","article-title":"Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients","volume":"35","author":"J A G\u00f3mez-Puerta","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/antib5030018","article-title":"Antiphospholipid antibodies: from general concepts to its relation with malignancies","volume":"5","author":"J A G\u00f3mez-Puerta","year":"2016","journal-title":"Antibodies (Basel)"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jcrc.2014.02.005","article-title":"Antiphospholipid antibodies in critically ill patients with cancer: a prospective cohort study","volume":"29","author":"J Vassalo","year":"2014","journal-title":"J Crit Care"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1191\/0961203303lu328oa","article-title":"High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis","volume":"12","author":"K H Yoon","year":"2003","journal-title":"Lupus"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s10067-005-0181-2","article-title":"Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies","volume":"25","author":"W Miesbach","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11739-009-0316-6","article-title":"Presence of low titre of antiphospholipid antibodies in cancer patients: a prospective study","volume":"4","author":"M Bazzan","year":"2009","journal-title":"Intern Emerg Med"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1096-8652(199707)55:3<167::AID-AJH12>3.0.CO;2-A","article-title":"Anti-phospholipid-antibody syndrome associated with peripheral T-cell lymphoma","volume":"55","author":"P Onida","year":"1997","journal-title":"Am J Hematol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/10428199609051629","article-title":"Progressive thrombosis after treatment of diffuse large cell non-Hodgkin's lymphoma and concomitant lupus anticoagulant","volume":"20","author":"Y K Keung","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00167001","article-title":"Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission","volume":"11","author":"M L Gruber","year":"1991","journal-title":"J Neurooncol"},{"issue":"02","key":"ref25","first-page":"57","article-title":"Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. [in Italian]","volume":"86","author":"A Sciarra","year":"1995","journal-title":"Recenti Prog Med"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.thj.6200377","article-title":"Antiphospholipid antibodies in lymphoma: prevalence and clinical significance","volume":"5","author":"S Pusterla","year":"2004","journal-title":"Hematol J"},{"issue":"03","key":"ref27","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000436","article-title":"The clinical significance of both IgM and IgG anticardiolipin antibodies in non-Hodgkin's lymphoma","volume":"7","author":"M M Saber","year":"2016","journal-title":"J Clin Cell Immunol"},{"key":"ref28","first-page":"1","volume-title":"Epidemiology of antiphospholipid antibodies and vascular disease","author":"D Tanne","year":"2000"},{"issue":"02","key":"ref29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2141.2003.04749.x","article-title":"Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases","volume":"124","author":"M B M\u00f8ller","year":"2004","journal-title":"Br J Haematol"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0002-9343(92)90049-H","article-title":"Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus","volume":"93","author":"J P Viard","year":"1992","journal-title":"Am J Med"},{"issue":"04","key":"ref31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0002-9343(99)00053-4","article-title":"Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients","volume":"106","author":"L G\u00f3mez-Pacheco","year":"1999","journal-title":"Am J Med"},{"issue":"05","key":"ref32","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1034\/j.1600-0609.2000.065005344.x","article-title":"Arterial thrombosis associated with anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphoma: a report of two cases","volume":"65","author":"I Genvresse","year":"2000","journal-title":"Eur J Haematol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9899.1000436","article-title":"The clinical significance of both IgM and IgG anti-cardiolipin antibodies in non-Hodgkin\u2019s lymphoma","volume":"7","author":"M M Saber","year":"2016","journal-title":"J Clin Cell Immunol"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1223-3367.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T23:42:08Z","timestamp":1609285328000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1223-3367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,15]]},"references-count":33,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2020,12,29]]},"published-print":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1223-3367","relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,15]]}}}